retatrutide clinical trial phase 3: TRIUMPH Program Results 2026 Retatrutide Availability & Timeline |

Expected Results: The theoretical outcome would be superior body recomposition: dramatic reduction in overall weight and visceral fat with exceptional preservation of lean muscle mass, leading to a lower body fat percentage and improved metabolic health

Key safety observations from available trial data include: Elevated resting heart rate in a dose-dependent manner Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) as the most common side effects, consistent with the GLP-1 receptor agonist class [1] [3] No clinically significant QT interval prolongation was reported in available data, though the extent of formal thorough QT assessment has not been fully detailed in published sources

For many, going needle-free alone is enough reason to consider switching

Tirzepatide produces about 20-22% weight loss

Sublingual GLP-1 drops have gained attention as a needle-free alternative to injectable semaglutide and tirzepatide

Wu T, Zhang Y, Shi Y, et al